Class II transactivator: mastering the art of major histocompatibility complex expression
about
Enhancement of CIITA transcriptional function by ubiquitinThe histone acetyltransferase domains of CREB-binding protein (CBP) and p300/CBP-associated factor are not necessary for cooperativity with the class II transactivatorRole of plasmacytoid dendritic cells for aberrant class II expression in exocrine glands from estrogen-deficient mice of healthy backgroundHistone deacetylase 1/mSin3A disrupts gamma interferon-induced CIITA function and major histocompatibility complex class II enhanceosome formationPositive regulatory domain I-binding factor 1 mediates repression of the MHC class II transactivator (CIITA) type IV promoterNew functions of the major histocompatibility complex class II-specific transcription factor RFXANK revealed by a high-resolution mutagenesis studyMitogen-activated protein kinase ERK1/2 regulates the class II transactivatorMurine NFX.1: isolation and characterization of its messenger RNA, mapping of its chromosomal location and assessment of its developmental expressionRegulation of major histocompatibility complex class II gene expression in trophoblast cellsOptimal MHC-II-restricted tumor antigen presentation to CD4+ T helper cells: the key issue for development of anti-tumor vaccinesAn MHC class II restriction bias in CD4 T cell responses toward I-A is altered to I-E in DM-deficient miceMinocycline down-regulates MHC II expression in microglia and macrophages through inhibition of IRF-1 and protein kinase C (PKC)alpha/betaIIClinical features of idiopathic inflammatory polymyopathy in the Hungarian Vizsla.Interferon gamma in successful pregnancies.Alarmins, inflammasomes and immunity.HSP-CBF is an NF-Y-dependent coactivator of the heat shock promoters CCAAT boxes.Two distinct domains within CIITA mediate self-association: involvement of the GTP-binding and leucine-rich repeat domainsHistone deacetylase activity represses gamma interferon-inducible HLA-DR gene expression following the establishment of a DNase I-hypersensitive chromatin conformation.Promoter-specific functions of CIITA and the MHC class II enhanceosome in transcriptional activationRegulation of antigen presentation by Mycobacterium tuberculosis: a role for Toll-like receptorsRegulation of major histocompatibility complex class II gene expression, genetic variation and disease.Novel functions for TAF7, a regulator of TAF1-independent transcription.Expression of the MHC class II transactivator (CIITA) type IV promoter in B lymphocytes and regulation by IFN-gamma.Inhibition of MHC II gene transcription by nitric oxide and antioxidants.Hexim1 sequesters positive transcription elongation factor b from the class II transactivator on MHC class II promoters.MHC class II transactivator (CIITA) expression is upregulated in multiple myeloma cells by IFN-gamma.Role of Annexin-II in GI cancers: interaction with gastrins/progastrins.Generation of antibody-producing hybridomas following one single immunization with a targeted DNA vaccineThe pIV-otal class II transactivator promoter regulates major histocompatibility complex class II expression in the thymus.Maturation of dendritic cells is accompanied by rapid transcriptional silencing of class II transactivator (CIITA) expression.Selective abrogation of major histocompatibility complex class II expression on extrahematopoietic cells in mice lacking promoter IV of the class II transactivator gene.CATERPILLERs, pyrin and hereditary immunological disorders.Histone deacetylases inhibit IFN-gamma-inducible gene expression in mouse trophoblast cellsMonarch-1/PYPAF7 and other CATERPILLER (CLR, NOD, NLR) proteins with negative regulatory functionsMX2 gene expression tends to be downregulated in subjects with HLA-DQB1*0602.CATERPILLER (NLR) family members as positive and negative regulators of inflammatory responses.Synthetic DNA vaccines: improved vaccine potency by electroporation and co-delivered genetic adjuvants.Hypothesis: sarcoidosis is a STAT1-mediated disease.CIITA and Its Dual Roles in MHC Gene Transcription.STAT3 and NF-κB are Simultaneously Suppressed in Dendritic Cells in Lung Cancer.
P2860
Q22330796-A5BF7F03-A5C9-4D7C-8C13-436CA29418D5Q22330805-EAA2C115-CA3D-4D0D-A16B-5FBB85524C4DQ24273412-291BD12A-B7A8-48D6-A751-BAED95E39D77Q24289051-CC130000-28A5-4929-8E4F-293889580AB8Q24289417-F7192B69-F44F-4EBC-9C1D-237C0770382BQ24534865-21C4DA55-7FDA-4EB1-A38A-14E300F533F8Q24652921-7BC9C56D-34E7-48AB-B07D-DF0F827637FBQ24682778-82A709CC-CF90-4DA7-91F4-26105D0D633EQ24793128-4B924A25-EC91-4328-9C77-BA8C27FFDE82Q27030560-B256894F-533A-4A0B-B833-060BE4E1A05BQ27469164-4CFC6EF6-79CA-4612-852A-E95D80BEAB75Q28576309-2565DDF0-EA1E-4133-A2FD-C4AA4F930D4CQ30645348-63F6AED5-DB19-403A-950A-BF02B3AAE471Q33770717-E9B246AD-50EA-466D-AB80-4B79055B97B0Q33817302-C08D9908-0F03-4924-8D35-D715E1AAB8F0Q33942761-9F1F6CE9-58CD-494D-AECF-6408370BEB51Q33967979-80050953-1385-4F3A-81BB-57839322B8E1Q34012255-713570CF-4DAA-4393-98CE-ECECC30B3762Q34086182-736700E0-222E-4AC9-B22C-505E6D37DA7EQ34104329-D0FBE51A-9892-47B1-9C1E-68C7F746DA84Q34330648-702825C1-C443-4C5C-B8E4-DC1E2C852431Q34385864-3019F2DB-2370-49BC-991B-B3102034B1B1Q34696238-6747650B-E9FC-4D74-92FC-B32CF05E75C4Q35699343-7A11501D-8801-4012-9081-40AE0A6E7359Q35768625-D010E8AF-FDD8-4E3A-9901-E861EFD0D77CQ35842817-EAC12F35-9645-404E-A323-00926FE98C50Q35928337-FC6ABF72-0F0F-4921-A939-BFF30E3ED7FEQ36158829-FD6D27DE-5A59-4994-B824-94DDB2871184Q36369511-F3ED4784-FCB0-43C2-880B-FB061FD50018Q36369559-B696E139-8B43-4713-BAB1-905000AE413AQ36369564-3E386C02-0FCB-48F9-A132-C1A4D4944D6AQ36405072-137C59DB-26A7-4F3D-ADCC-86C67EBB5CDBQ36425139-4D731358-411F-462E-AE3D-61396BE3D9ADQ36453716-01ECBD63-E390-4233-A04B-3F53D1308502Q36681431-98C6CB6E-E6B4-4CF1-9A30-13B3B075D1E5Q36868300-0F8A4599-C0CC-4BC2-9492-CE6C0206B137Q37276912-5FC4A26D-BDF5-4737-B19C-18F9F35278EEQ37323719-51773F27-1589-4111-9F3A-F2A8D05BD2BCQ37405448-EEEB7791-F1EC-40A2-807E-6236BBF4A0E9Q37724334-28BB114F-35B9-4A39-89D3-E4EA70EA00AB
P2860
Class II transactivator: mastering the art of major histocompatibility complex expression
description
2000 nî lūn-bûn
@nan
2000 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Class II transactivator: mastering the art of major histocompatibility complex expression
@ast
Class II transactivator: mastering the art of major histocompatibility complex expression
@en
Class II transactivator: mastering the art of major histocompatibility complex expression
@nl
type
label
Class II transactivator: mastering the art of major histocompatibility complex expression
@ast
Class II transactivator: mastering the art of major histocompatibility complex expression
@en
Class II transactivator: mastering the art of major histocompatibility complex expression
@nl
prefLabel
Class II transactivator: mastering the art of major histocompatibility complex expression
@ast
Class II transactivator: mastering the art of major histocompatibility complex expression
@en
Class II transactivator: mastering the art of major histocompatibility complex expression
@nl
P2860
P1476
Class II transactivator: mastering the art of major histocompatibility complex expression
@en
P2093
P2860
P304
P356
10.1128/MCB.20.17.6185-6194.2000
P407
P577
2000-09-01T00:00:00Z